(Logo: http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO)
(Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO)
About Cardium
Cardium is focused on the acquisition and strategic development of new and innovative bio-medical product opportunities and businesses that have the potential to address significant unmet medical needs and definable pathways to commercialization, partnering and other economic monetizations. Cardium's investment portfolio includes the Tissue Repair Company and Cardium Biologics, medical technology companies primarily focused on the development of innovative therapeutic products for wound healing, bone repair, and cardiovascular indications. In July 2009, Cardium completed the sale of its InnerCool Therapies medical device business to Royal Philips Electronics, the first asset monetization from the Company's biomedical investment portfolio. News from Cardium is located at www.cardiumthx.com.
Copyright 2010 Cardium Therapeutics, Inc. All rights reserved. For Terms of Use Privacy Policy, please visit www.cardiumthx.com. Cardium Therapeutics Generx® and MedPodium are trademarks of Cardium Therapeutics, Inc.Tissue Repair, Gene Activated Matrix, GAM, Excellagen, Excellarate, Osteorate, Appexium and Linee are trademarks of Tissue Repair Company. (Other trademarks belong to their respective owners)
SOURCE Cardium Therapeutics
